Abstract
Temporin-1Vb, -1Oe, -1DRb, and -1TGb (10-8 - 10-6M) produced significant (p < 0.05) and concentrationdependent stimulatory effects on insulin secretion from clonal rat BRIN-BD11 cells without increased release of lactate dehydrogenase. Temporin-1Va and temporin-1Vc (10-8 - 10-6M) also stimulated insulin-release but were cytotoxic at 10-6M. Temporin-1DRa was without effect. The temporins at 10-7 M had no effect on intracellular calcium concentrations suggesting that they stimulate insulin release via a KATP channel- independent pathway.
Keywords: Amphibian skin, insulin secretion, temporin, cytolysis
Protein & Peptide Letters
Title: Insulin Releasing Properties of the Temporin Family of Antimicrobial Peptides
Volume: 14 Issue: 7
Author(s): Yasser H.A. Abdel-Wahab, Lamin Marenah, Peter R Flatt and J. Michael Conlon
Affiliation:
Keywords: Amphibian skin, insulin secretion, temporin, cytolysis
Abstract: Temporin-1Vb, -1Oe, -1DRb, and -1TGb (10-8 - 10-6M) produced significant (p < 0.05) and concentrationdependent stimulatory effects on insulin secretion from clonal rat BRIN-BD11 cells without increased release of lactate dehydrogenase. Temporin-1Va and temporin-1Vc (10-8 - 10-6M) also stimulated insulin-release but were cytotoxic at 10-6M. Temporin-1DRa was without effect. The temporins at 10-7 M had no effect on intracellular calcium concentrations suggesting that they stimulate insulin release via a KATP channel- independent pathway.
Export Options
About this article
Cite this article as:
Yasser H.A. Abdel-Wahab , Lamin Marenah , Peter R Flatt and J. Michael Conlon , Insulin Releasing Properties of the Temporin Family of Antimicrobial Peptides, Protein & Peptide Letters 2007; 14 (7) . https://dx.doi.org/10.2174/092986607781483822
DOI https://dx.doi.org/10.2174/092986607781483822 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Xanthone Derivatives: New Insights in Biological Activities
Current Medicinal Chemistry Protease-Activated Receptor-2 Antagonists and Agonists
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Design of Multifunctional Compounds for Cardiovascular Disease: From Natural Scaffolds to “Classical” Multitarget Approach
Current Medicinal Chemistry Antiproliferative Activity of Olive Oil Phenolics against Human Melan oma Cells
Letters in Drug Design & Discovery The Development of PDGF Receptor Inhibitors for the Treatment of Glioma: A Review
Letters in Drug Design & Discovery The Metabolism of Anthocyanins
Current Drug Metabolism Recent Advances in Drug Design of Epidermal Growth Factor Receptor Inhibitors
Current Medicinal Chemistry Regulation and Importance of the PI3K/Akt/mTOR Signaling Pathway in Hematologic Malignancies
Anti-Cancer Agents in Medicinal Chemistry Magnetic Nanoparticles for MRI of Brain Tumors
Current Pharmaceutical Biotechnology Sunscreening and Photosensitizing Properties of Coumarins and their Derivatives
Letters in Drug Design & Discovery Phosphonic Esters and their Application of Protease Control
Current Pharmaceutical Design Structure-Activity Relationship Studies: Methods and Ligand Design for G-Protein Coupled Peptide Receptors
Current Protein & Peptide Science Cardiotoxicity of 5-Fluorouracil
Cardiovascular & Hematological Agents in Medicinal Chemistry Recent Trends in Tubulin-Binding Combretastatin A-4 Analogs for Anticancer Drug Development
Current Medicinal Chemistry The Use of Progesterone in Clinical Practice: Evaluation of its Efficacy in Diverse Indications Using Different Routes of Administration
Current Drug Therapy Analytical Methods for Determination of ·NO and ·NO2 and their Applicability in Biological Studies
Current Pharmaceutical Analysis Engineered Silver Nanoparticles, A New Nanoweapon Against Cancer
Anti-Cancer Agents in Medicinal Chemistry Adrenomedullin in Hypertension
Current Hypertension Reviews Selective Cyclooxygenase Inhibitors: Current Status
Current Drug Discovery Technologies Structures Required of Polyphenols for Inhibiting Advanced Glycation end Products Formation
Current Drug Metabolism